International Flavors & Fragrances Inc. (IFF)

NYSE: IFF · Real-Time Price · USD

84.28

+0.89 (1.07%)

At close: Aug 21, 2026, 4:00 PM EDT

85.00

+0.72 (0.85%)

Pre-market: Aug 24, 2026, 7:29 AM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Taste Revenue	2.57B	2.48B	2.43B
Food Ingredients Revenue	-	3.28B	3.37B
Health & Biosciences Revenue	2.36B	2.28B	2.20B
Scent Revenue	2.58B	2.48B	2.44B
Pharma Solutions Revenue	-	369.00M	1.05B
Revenue (Other)	2.47B	-	-
Revenue (Total)	9.98B	10.89B	11.48B

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Taste Adjusted Operating EBITDA	499.00M	478.00M	460.00M
Food Ingredients Adjusted Operating EBITDA	-	423.00M	408.00M
Health & Biosciences Adjusted Operating EBITDA	608.00M	594.00M	577.00M
Scent Adjusted Operating EBITDA	523.00M	515.00M	545.00M
Pharma Solutions Adjusted Operating EBITDA	-	76.00M	215.00M
Operating Income (Total)	754.00M	-382.00M	766.00M

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Nourish Capital Expenditures	322.00M	235.00M
Health & Biosciences Capital Expenditures	145.00M	73.00M
Scent Capital Expenditures	89.00M	70.00M
Pharma Solutions Capital Expenditures	38.00M	85.00M

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Taste - Comparable Currency Neutral Sales Growth	4.00%	-
Food Ingredients - Comparable Currency Neutral Sales Growth	-3.00%	-
Health & Biosciences - Comparable Currency Neutral Sales Growth	3.00%	8.00%
Scent - Comparable Currency Neutral Sales Growth	3.00%	12.00%
Pharma Solutions - Comparable Currency Neutral Sales Growth	12.00%	2.00%
Consolidated Comparable Currency Neutral Sales Growth	2.00%	6.00%